Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 12, 2012
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.
read more
Tuesday, December 11, 2012
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed Timothy Rhines, Ph.D., RAC as the company’s senior director of biopharmaceutical development for its ...
read more
Wednesday, January 23, 2013
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today the expansion of laboratory service offerings, capabilities and instrumentation in its state-of-the-art laboratory Technology ...
read more
Thursday, February 06, 2014
AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development ...
read more
Wednesday, April 25, 2012
AAIPharma Services Corp., a leading provider of product-development services for the pharmaceutical industry, today officially opens a 40,000 square foot, state-of-the-art Technology Center on its Wilmington, N.C., headquarters campus as part of a $...
read more
Thursday, October 31, 2013
“The launch of the new brand logo is an outward sign of an important transformation that’s been ongoing for the past couple of years,” said John D. Bucksath, President and CEO. “The entire organization has worked very hard to get where we are today. ...
read more
Wednesday, August 01, 2012
Advanced BioScience Laboratories, Inc. (ABL, Inc.) announced today the award of a contract to provide the NIH National Institute of Allergy and Infectious Diseases (NIAID) with preclinical development and cGMP manufacturing support for multiple ...
read more
ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, has advanced its hybrid central lab model in Mumbai with a state-of-the art operational facility dedicated to manage ...
read more
ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, is pleased to announce that Isabel Struik has joined the executive management team as head of business development in ...
read more
Friday, November 20, 2020
ADVAITE announced the company's high complexity CLIA laboratory operating out of Chicago, IL has been authorized to offer Yale University's SalivaDirect test.
read more
April 3, 2012 - Charles River Discovery Services is partnering with Metabolon to better meet your oncology research needs. Through this collaboration, Charles River’s preclinical oncology study expertise can be leveraged with Metabolon’s in-depth ...
read more
Thursday, September 13, 2012
AIT Bioscience is pleased to announce that Dr.Ron Bowsher, an industry expert in bioanalysis of ligand binding assays, has partnered with the company as a senior research advisor bringing with him an impressive background in biotherapeutic drug ...
read more
AIT Laboratories (AIT) announces the appointment of R. Matthew Neff as President and Chief Executive Officer of the company, effective August 5, 2013. Neff will also remain in his role as Chairman of the Board for the company. Dr. Michael Evans, the...
read more
Thursday, December 10, 2015
Ajinomoto Althea, Inc. (“Althea”) recently announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs).
read more
Akoya Biosciences Inc. and The Spatial Biology Company® announced a collaboration with AstraZeneca to advance new multiplex immunofluorescence (mIF) workflows and spatial biomarker signatures, based on Akoya’s Phenoptics™ platform. The agreement ...
read more